Press Releases | Liechtenstein Industry Review

April 8, 2025

OilXCoin's Prospectus Secures First Regulatory Approval For A Very Unique Security Token Backed by Oil & Gas

GlobeNewswire, Inc.

March 17, 2025

The Dealmakers Spotlight Ocean Quest’s AI & Robotics Advancing Global Sustainability at Investors Roundtable in Dubai

EIN Presswire

June 20, 2025

argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy

GlobeNewswire, Inc.

March 28, 2025

Legacy Network Powers Up Education With Major Blockchain Move – $LGCT Set To Become Global Currency Of Learning

GlobeNewswire, Inc.

June 15, 2025

EU Defends Schengen as Border Controls Mount Across Bloc

MENAFN

Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate

Owned By	Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded	2000
Website	menafn.com
Domain Registration Year	Indeterminate
Access Type	open
Publication Location	Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

June 14, 2025

EU Reach Forty Years of Schengen Agreement

MENAFN

Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate

Owned By	Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded	2000
Website	menafn.com
Domain Registration Year	Indeterminate
Access Type	open
Publication Location	Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

June 6, 2025

European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy

GlobeNewswire, Inc.

January 13, 2025

Power Tools Market Growth Surge Expected as Market Size Hits USD 69,089.4 Billion by 2032 with CAGR 6.26%

EIN Presswire

February 27, 2025

German Blockchain & AI Week 2025: Agenda BEAM – 'Bridging European and Asian Markets'

GlobeNewswire, Inc.

January 14, 2025

Beam Global Announces EV ARC™ System Meets CE Mark Compliance

GlobeNewswire, Inc.

April 23, 2025

Opterro, Inc. and Polytec GmbH Announce Strategic Distribution Agreement Across Eight European Countries

EIN Presswire

May 8, 2025

Ligand Reports First Quarter 2025 Financial Results

GlobeNewswire, Inc.

April 28, 2025

argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

GlobeNewswire, Inc.

April 28, 2025

Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa

GlobeNewswire, Inc.

April 15, 2025

Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union

GlobeNewswire, Inc.

April 23, 2025

Norway, Poland Formalize New Agreement

MENAFN

Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate

Owned By	Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded	2000
Website	menafn.com
Domain Registration Year	Indeterminate
Access Type	open
Publication Location	Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

April 1, 2025

Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above

GlobeNewswire, Inc.

April 16, 2025

Basilea reports presentation of new data for fosmanogepix, isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) at ESCMID Global 2025

GlobeNewswire, Inc.

$Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)$

July 21, 2025

Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)

GlobeNewswire, Inc.

March 29, 2025

Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates

GlobeNewswire, Inc.